RxDoctor Payments Data

Mary Kim, MD

Plastic and Reconstructive Surgery · Shreveport, LANPI 1033192828

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for plastic and reconstructive surgery clinicians in LA, where the typical reported total is $2,109.

$609in general payments, 2019–2025

Across 15 payments — averaging $40.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$116
  • Mimedx Group, Inc.$113
  • Axogen$108
  • Integra Lifesciences Corporation$95
  • Johnson & Johnson$52
  • Mentor Worldwide LLC$40
  • plus $86 from 5 others

What the payments were for

  • Food & beverage$609100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$609 in reported general payments places this provider in the 25th percentile of 45 plastic and reconstructive surgery providers in Louisiana.

See all plastic and reconstructive surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$23,086
Medicare patients
27
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →